CRISPR

FDA approves two sickle cell anemia treatments, one using CRISPR gene editing – The New York Times

On Friday, the Food and Drug Administration approved the first gene-editing therapy ever used in humans to treat sickle cell anemia, a debilitating blood disorder caused by a single mutated gene. The agency also approved a second conventional gene therapy treatment for sickle cell disease that does not use gene editing. For the 100,000 sick … [Read more…]

188 Types of “New CRISPR Systems” Updated | Genetics – genetics

Scientists at the McGovern Institute for Brain Research, the Broad Institute of MIT and Harvard, and the National Center for Biotechnology Information (NCBI) at the National Institutes of Health (NIH) developed a new search algorithm that made it possible to identify “188 types of new CRISPR.” identify systems [1] », rare in bacterial genomes, includes … [Read more…]